KLRG1 and neoplasm: Additionally, we saw that KLRG1 had drastically reduced cytotoxicity, often only killing between 0 and 20% of K562 tumor cells, compared to the CD3ζ-only CAR, which killed approximately 75% of tumor cells at each timepoint (Fig. 5C to E).